Who Owns Ivoclar?
Ivoclar is owned by Ivoclar Vivadent AG, a family-owned dental company headquartered in Schaan, Liechtenstein. The company rebranded from Ivoclar Vivadent to the single name Ivoclar in 2022 while keeping its legal name unchanged. Founded in 1923, it is controlled by the Zeller family and sells dental materials and equipment through 56 subsidiaries to about 130 countries, generating 856 million Swiss francs in FY2023 revenue.
Who Owns Ivoclar?
- Parent Company: Ivoclar Vivadent AG
- Ownership Type: Wholly owned
- Company Type: Privately Held
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Ivoclar | Ivoclar Vivadent AG | Wholly owned |
Where to Buy
Disclosure: We may earn commission from purchases
Ivoclar on AmazonAdvertisement
History of Ivoclar
- Founded: 1923
- Founders: Dr. Adolf Schneider
The company began in 1923 in Zurich, Switzerland, when Dr. Adolf Schneider founded a firm to manufacture artificial teeth. The name Ivoclar came from the ivory-like material used in its early denture products.
In 1933 the business relocated to Liechtenstein, where it has remained for more than 90 years. It expanded from denture teeth into a full range of dental materials and equipment, earning a reputation in ceramics and restorative systems under Zeller family ownership.
The Vivadent name was added in the 1950s, and the company operated as Ivoclar Vivadent for decades while building a global subsidiary network. It became a leader in all-ceramic restorations through products such as IPS e.max, introduced in the 2000s and now a category standard in dental laboratories.
In 2022 it dropped Vivadent from the public-facing brand and simplified to Ivoclar, while retaining Ivoclar Vivadent AG as the legal name. A new headquarters building in Schaan opened in 2023 for the company's centennial. In 2024 it announced a reorganization cutting about 240 positions to address currency and cost pressure, paired with continued investment in digital dentistry.
Advertisement
About Ivoclar Vivadent AG
What does Ivoclar own?
Ivoclar owns dental product lines including IPS e.max ceramics, Bluephase curing lights, Programat furnaces, and digital dentistry systems. It operates 56 subsidiaries worldwide but sells under one master brand.
Is Ivoclar publicly traded?
No. Ivoclar is a private, family-owned company with no stock listing.
Advertisement
Who founded Ivoclar?
Dr. Adolf Schneider founded the company in Zurich in 1923 to manufacture artificial teeth. It has been controlled by the Zeller family for much of its later history.
Where is Ivoclar headquartered?
The company is headquartered in Schaan, Liechtenstein, where it has been based since relocating from Switzerland in 1933.
Advertisement
How many brands does Ivoclar own?
It operates primarily under the single Ivoclar master brand, with product families such as IPS e.max, Bluephase, and Programat rather than a multi-brand portfolio.
Who owns Ivoclar?
The Zeller family owns Ivoclar through family holdings. Christoph Zeller is the principal owner, and the company is family controlled across generations.
Advertisement
What is Ivoclar's revenue?
The company reported 856 million Swiss francs in revenue for fiscal year 2023. It does not release detailed public financial statements beyond headline figures.
- Founded: 1923
- Headquarters: Schaan, Liechtenstein
- Company Type: Privately Held
- Revenue: 856 million CHF (FY2023)
- Employees: Approximately 3,700
Where Is Ivoclar Made / Based?
- Headquarters: Schaan, Liechtenstein
- Manufacturing / Operations: Liechtenstein, Austria, Italy, United States, Philippines
Ivoclar Categories & Tags
Ivoclar Sustainability & Ethics
Ivoclar reports sustainability efforts centered on manufacturing efficiency, training, and education in its markets. It does not carry third-party consumer certifications such as B Corp status, and its ESG posture is communicated through company reporting rather than independent labels.
Its regulatory framework is medical device compliance. Products meet ISO standards and EU MDR and FDA requirements for dental materials and equipment, which is the relevant accountability layer for a supplier of this type.
Advertisement
Ivoclar Recalls & Controversies
The brand has a clean regulatory record typical of a materials supplier, with product issues handled as technical corrections rather than major recalls. No significant safety scandals are on record.
The most visible recent event was the 2024 reorganization and approximately 240 job cuts, which drew regional attention because the company is a major employer in Liechtenstein and the surrounding area. The reductions were tied to currency and cost pressure rather than declining demand.
Ivoclar Ownership: Pros & Cons
Advantages
- +Family ownership enables long-term R&D without quarterly earnings pressure
- +Leading position in all-ceramic materials is a durable technical moat
- +Direct subsidiary network in 56 countries controls distribution
- +Training centers create customer loyalty and switching costs
- +Centuries-deep expertise concentrates on one industry
Considerations
- -No public equity access limits capital for large acquisitions
- -Swiss-franc cost base creates currency exposure for exports
- -Family succession and ownership concentration shape strategy
- -Larger diversified competitors can bundle broader portfolios
- -Recent layoffs signal margin pressure despite market position
Advertisement
Frequently Asked Questions About Ivoclar
Sources & Further Reading
Advertisement
Competitors to Ivoclar
No direct competitors found in the same category. This could be because Ivoclaroperates in a unique market segment or we're still building our competitor database.
Advertisement
Independent Alternatives to Ivoclar
Looking for brands with different ownership structures? These similar brands are not owned by Ivoclar Vivadent AG, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsArthrex
Owned by Arthrex Inc.
Orthopedic device brand of privately held Arthrex Inc., specializing in arthroscopic surgery products sold in more than 100 countries.
orthopedic-devicesarthroscopysports-medicine
Privately Owned
Arthrex operates independently without a large parent corporation.
Healthcare PharmaceuticalsPhilips
Owned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
healthcare-technologyelectronicsmedical-devices
Publicly Traded
Philips operates independently without a large parent corporation.
Healthcare PharmaceuticalsSmith+Nephew
Owned by Smith+Nephew plc
British medical technology company founded in 1856, reporting $6.16 billion in FY2025 revenue across orthopaedics, sports medicine, and advanced wound management, listed on the London Stock Exchange.
medical-devicesorthopedicswound-care
Publicly Traded
Smith+Nephew operates independently without a large parent corporation.
Healthcare PharmaceuticalsZimmer Biomet
Owned by Zimmer Biomet Holdings, Inc.
Zimmer Biomet is the flagship orthopedic brand of Zimmer Biomet Holdings, producing knee, hip, and trauma implants plus the ROSA surgical robotics platform from its Warsaw, Indiana base.
orthopedicsmedical-devicesimplants
Publicly Traded
Zimmer Biomet operates independently without a large parent corporation.
Healthcare PharmaceuticalsGE HealthCare
Owned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
healthcare-technologymedical-imagingdiagnostics
Publicly Traded
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsHCA Healthcare
Owned by HCA Healthcare, Inc.
HCA Healthcare is the flagship brand of the largest U.S. for-profit hospital operator, a network of 190 hospitals and about 2,500 ambulatory sites across 19 states and England.
hospitalshealthcareemergency-care
Publicly Traded
HCA Healthcare operates independently without a large parent corporation.
Jobs at Ivoclar Vivadent AG
Advertisement
Latest News About Ivoclar
Related Articles About Ivoclar
View more articles
Health
Hospital and Clinic Brand Ownership
HCA Healthcare is the largest for-profit hospital system (190 hospitals, $75.6B revenue). Tenet has 50 hospitals ($21.3B). UHS has 346 behavioral facilities. Fresenius leads dialysis. Explore our database.
Who Brands StaffNov 14, 2026
Hca HealthcareTenet HealthUhs
Health
Eye Care Brand Ownership: Bausch & Lomb to Alcon
J&J Vision (Acuvue) leads contact lenses at 27-30%. Alcon (Novartis spin-off) holds 25-27%. CooperVision has 22-24%. Bausch + Lomb has 12-15%. EssilorLuxottica dominates lenses at 30.7%. Explore our database.
Who Brands StaffNov 13, 2026
Bausch LombAlconCoopervision
Health
Dental Brand Ownership Beyond Colgate and Crest
Colgate holds 41.3% global toothpaste share. P&G (Crest, Oral-B) has 14.1%. Haleon (Sensodyne) has 4.4%. Church & Dwight is the only independent at scale. The oral care market is $47.2B. Explore our database.
Who Brands StaffNov 12, 2026
ColgateCrestOral B
Advertisement
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandgenetic-testing
23andMe
Consumer DNA testing brand now run as a nonprofit under TTAM Research Institute following the 2025 bankruptcy sale of 23andMe Holding Co.
Brand in Healthcare & Pharmaceuticals
dna-kitsconsumer-genomics
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandmedical-devices
Abbott Medical Devices
Abbott Laboratories' medical device business spanning cardiovascular, diabetes care (FreeStyle Libre), neuromodulation, and structural heart, generating roughly $20 billion annually.
Brand in Healthcare & Pharmaceuticals
cardiovasculardiabetes-care